InsiderClue
Insiders · Profile

CHASE ANTHONY R

Director at LyondellBasell · Director at CULLEN/FROST BANKERS · Director at Sarepta Therapeutics. Filing since 12 May 2010. CIK 0001223756

LYB LyondellBasell Director · 7 trades CFR CULLEN/FROST BANKERS, INC. Director · 1 trade SRPT Sarepta Therapeutics, Inc. Director · 13 trades
Company
Date
Role
Action
Shares
Amount
Of holding
LYB LyondellBasell
25 Apr 2023
Director
Sold at will
1
$91.36
0.0%
LYB LyondellBasell
6 Dec 2022
Director
Bought
1
$82.30
0.0%
LYB LyondellBasell
3 Oct 2022
Director
Sold at will
10
$782.20
0.2%
LYB LyondellBasell
1 Sep 2022
Director
Bought
10
$818.60
0.2%
LYB LyondellBasell
26 Jul 2022
Director
Sold at will
25
$2.19K
0.4%
LYB LyondellBasell
23 Jun 2022
Director
Bought
2
$169.00
0.0%
CFR CULLEN/FROST BANKERS, INC.
23 Jun 2022
Director
Bought
1
$109.00
opened
LYB LyondellBasell
10 Dec 2021
Director
Bought
25
$2.25K
0.4%
SRPT Sarepta Therapeutics, Inc.
14 Nov 2013
Director
Bought
10,000
$139.48K
31.5%
SRPT Sarepta Therapeutics, Inc.
22 Aug 2013
Director
Bought
3,500
$114.37K
12.4%
SRPT Sarepta Therapeutics, Inc.
14 Jun 2013
Director
Bought
10,000
$385.04K
54.8%
SRPT Sarepta Therapeutics, Inc.
28 Nov 2012
Director
Sold, plan not stated
8,900
$262.69K
34.0%
SRPT Sarepta Therapeutics, Inc.
27 Nov 2012
Director
Sold, plan not stated
1,100
$31.94K
4.0%
SRPT Sarepta Therapeutics, Inc.
14 Nov 2012
Director
Sold, plan not stated
10,000
$257.00K
26.9%
SRPT Sarepta Therapeutics, Inc.
7 Sep 2012
Director
Sold, plan not stated
33,000
$476.96K
47.0%
SRPT Sarepta Therapeutics, Inc.
13 Sep 2011
Director
Bought
20,000
$24.00K
5.0%
SRPT Sarepta Therapeutics, Inc.
9 Jun 2010
Director
Bought
46,500
$65.89K
13.5%
SRPT Sarepta Therapeutics, Inc.
21 May 2010
Director
Bought
50,000
$66.50K
17.0%
SRPT Sarepta Therapeutics, Inc.
18 May 2010
Director
Bought
11,068
$15.92K
3.9%
SRPT Sarepta Therapeutics, Inc.
17 May 2010
Director
Bought
18,539
$26.14K
7.0%
SRPT Sarepta Therapeutics, Inc.
12 May 2010
Director
Bought
96,000
$129.60K
56.7%
21 decisions on file.